Sameek Roychowdhury is a graduate of The Ohio State University, B.S. Molecular Genetics 98’, Ph.D. 04’, M.D. 06’. He completed his Ph.D. dissertation research with his mentor Michael Caligiuri, M.D., studying cancer immunology and experimental therapeutics. He completed his internal medicine and medical oncology training at University of Michigan (2006-2011) with Arul Chinnaiyan, M.D., Ph.D. During his medical oncology fellowship, he trained with Dr. Chinnaiyan in the field of Translational Cancer Genomics to apply cutting edge genetic tools for individual patients participating in clinical trials to further develop an approach for personalized cancer medicine. As a junior faculty he received the Landon Foundation-American Association for Cancer Research’s Innovator Award for Personalized Cancer Medicine (2012). He relocated to The Ohio State University’s Comprehensive Cancer Center in September 2012 and his research lab seeks to co-develop clinical trials that implement therapies through the understanding of an individual patient’s cancer gene mutations.
Dr. Roychowdhury is a physician scientist whose research interests involve translating next generation DNA sequencing strategies for the development of genomics-driven clinical trials. He joined the Division of Medical Oncology in September 2012. His clinical study entitled “Personalized Oncology Through High-Throughout Sequencing” evaluates individual patients with advanced cancer considering clinical trials, and seeks to identify “driving” mutations that match novel molecularly targeted therapies in development. The overarching goal is to identify putative predictive genomic biomarkers for targeted therapies and understand primary and secondary resistance mechanisms for these therapies. His clinical practice in medical oncology includes patients with advanced cancer including prostate, colorectal, soft tissue sarcoma, and rare cancer subtypes. Dr. Roychowdhury's CV